Bicara Therapeutics Inc. Common Stock Financial Flexibility Index
Bicara Therapeutics Inc. Common Stock financial flexibility index. Bicara Therapeutics Inc. Common Stock (BCAX) has a Financial Flexibility Index of -1.02x as of June 2026. Free cash flow of $-44.15 Million (operating CF $-44.21 Million minus capex $60.00K) represents -1% of total liabilities ($43.48 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Bicara Therapeutics Inc. Common Stock (2022–2025)
Financial flexibility index of Bicara Therapeutics Inc. Common Stock from 2022 to 2025. Historical Financial Flexibility Index trend for Bicara Therapeutics Inc. Common Stock across 4 annual periods. Explore Bicara Therapeutics Inc. Common Stock debt service capacity to assess how comfortably operating cash covers total debt obligations.
Bicara Therapeutics Inc. Common Stock Financial Flexibility Index by Year (2022–2025)
Bicara Therapeutics Inc. Common Stock financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Bicara Therapeutics Inc. Common Stock. For the full cash flow conversion analysis, see cash flow conversion of Bicara Therapeutics Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.61x | $-106.55 Million | $-106.83 Million | $29.54 Million | ▼ -273.4% |
| 2024 | -0.97x | $-74.68 Million | $-74.75 Million | $77.32 Million | ▲ +66.8% |
| 2023 | -2.91x | $-45.04 Million | $-45.63 Million | $15.47 Million | ▼ -118.9% |
| 2022 | -1.33x | $-31.88 Million | $-32.08 Million | $23.98 Million | — |